SRDX - Surmodics Non-GAAP EPS of -$0.26 beats by $0.19 revenue of $26M beats by $1.91M
- Surmodics press release ( NASDAQ: SRDX ): Q4 Non-GAAP EPS of -$0.26 beats by $0.19 .
- Revenue of $26M (+16.6% Y/Y) beats by $1.91M .
-
Fiscal Year 2022 Financial Summary
-
Total Revenue of $100.0 million vs $98.05M Consensus a decrease of 5% year-over-year
-
GAAP Diluted EPS of $(1.96) vs -$1.15 Consensus including $(0.73) deferred tax valuation reserve, compared to $0.30 in the prior-year perio
-
Non-GAAP Diluted EPS of $(0.95), compared to $0.37 in the prior-year period
For further details see:
Surmodics Non-GAAP EPS of -$0.26 beats by $0.19, revenue of $26M beats by $1.91M